MeTA Philippines Roberto M. Pagdanganan

Slides:



Advertisements
Similar presentations
CIVICUS World Alliance for Citizen Participation Transparency Key messages to increase the transparency and the predictability of aid.
Advertisements

Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Promoting patient-centred healthcare around the world A patient perspective on the multiple policy initiatives: Lessons learnt – assessing the gaps Joanna.
Boosting Non State Actor participation in CAADP Yaoundé 24 th March 7 Th CAADP PP CAADP NSA Coordination Task Team.
First Evaluation of Good Governance for Medicines Programme Brief Summary of Findings.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
EQUITABLE PARTNERSHIPS WITH CIVIL SOCIETY ORGANIZATIONS WILL ACHIEVE THE MILLENNIUM DEVELOPMENT GOALS JIMMY GOTYANA NATIONAL PRESIDENT: SANGOCO SEPTEMBER.
Community-Based Participatory Research
Organizational profiling and learning needs assessment ANSA EAP Mongolia Conveners Group Strategic planning workshop Khaan Jim, June 2010.
Revitalizing radical social work in 21st century: practical opportunities for social change Ana Miljenović, prof. Nino Žganec Study Centre for Social Work,
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS AND PROGRAMMES presented by Faizal Parish Regional/Central Focal Point GEF NGO.
TB/HIV COMMUNITY MOBILIZATION IN AFRICA: Ongoing activities, achievements and challenges Paula Akugizibwe, AIDS and Rights Alliance for Southern AFrica.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
An Overview Presentation to Senate Committee on Human Rights December 13, 2004.
Medicines Transparency Alliance13/09/ MeTA Uganda Country Overview Public Sector Private Sector Civil Society.
MULTI-STAKEHOLDER COLLABORATION: CAN IT IMPROVE TRANSPARENCY, DISCLOSURE AND ACCESS TO MEDICINES? EXPERIENCES FROM 7 META PILOT COUNTRIES Wilbert Bannenberg.
Medicines Transparency Alliance MeTA GhanaMeTA Philippines MeTA JordanMeTA Uganda MeTA PeruMeTA Zambia Pilot Countries View from the Private Sector 23/09/2015.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Medicines Transparency Alliance03/10/ MeTA Zambia Violet Kabwe MeTA Zambia Consultant.
Corporate Governance in the Caribbean Environment “The Caribbean Corporate Governance Forum” Trevor E Blake General Manager – ECSE.
“Public-Private Health Forum guiding the way forward for partnerships to improve health in Tanzania” Dr. Adeline Kimambo Co-Chair PPHF Executive Board.
Contact Monitoring Regional Network (CMKN). Why procurement It is estimated that an effective public procurement system could save as much as 25% of government.
The implementation of the European Commission Recommendation Investing in Children Mafalda Leal Senior Policy Coordinator 7th Regional Meeting of NGOs.
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Presented by: D. Maxim Kumeh-PRSTN Grand Bassa, Buchanan City November 15, 2012 follow the money.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.
META PHILIPPINES WORKPLAN : EARLY ACCOMPLISHMENTS IN THE PILOT PHASE.
Education and MDGs The MDGs provided a powerful framework However, there are weaknesses: – Equity – Interconnectivity of issues – Sustainable development.
La MANCHE Virtual Think Tank. Virtual Think Tank: Mission represents an innovative internet based community which initiates and encourages sustainable.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS presented by Ermath Harrington GEF Regional Focal Point.
Results Focus is Focusing on the Solution: SHIFTING FROM AID THAT WORKS TO DEVELOPMENT THAT WORKS Richard Ssewakiryanga Executive Director Uganda National.
Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
 Introduction  Local AIDS Governance Barometer (LAGB) Model  LAGB Purpose  LAGB Application – Kabwe district, Zambia  LAGB’s Contribution to the.
Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
Trilateral Development Cooperation: How to make it more Effective? Global Partnership for Development Conference New Delhi 13 August 2008 Roger Nellist.
Medicines Transparency Alliance31/01/ MeTA Uganda Jacqueline Idusso Secretariat Coordinator.
The GEF Monitoring and Evaluation Policy. 2  Result-Based Management (RBM) - setting goals and objectives, monitoring, learning and decision making 
GFG-BACG Meeting: Harnosand, Sweden March 14,
Wilbert Bannenberg Technical Director, Intl MeTA Secretariat 28 April 2010, IPC meeting, Copenhagen Medicines Transparency Alliance: improving people’s.
1 CIVIL SOCIETY AND CORPORATE SOCIAL RESPONSIBILITY IN VIETNAM: BRIDGING THE GAP Hanoi, March 2013.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
Ministry of Finance of Georgia Fiscal Transparency Natia Gulua Head of Budget Policy Division Budget Department – MOF
The Medicines Transparency Alliance Saul Walker Senior Policy Advisor, Access to Medicines Health Services Team.
Fiscal transparency Open Budget Surveys
SADC Medicines Database (SMD)
Progress on Aid Effectiveness: Monitoring the Global Partnership and the Moldova Partnership Principles Lucreția Ciurea, State Chancellery Jakob Schemel,
GEF Familiarization Seminar
Revising GEF’s M&E Policy
Institutional Strengthening Support
GEF governance reforms to enhance effectiveness and civil society engagement Faizal Parish GEC, Central Focal Point , GEF NGO Network GEF-NGO Consultation.
e-Procurement Learning Series
IFP TANZANIA PRESENTATION AT THE ROUND TABLE MEETING , NAIROBI KENYA
BUDESHI PROGRAM DIRECTOR PUBLIC AND PRIVATE DEVELOPMENT CENTRE (PPDC)
Presentation about BILAT USA 4.0
Macro-Fiscal Policy Unit/ Ministry of Finance Egypt
GIFT and IBP Pilot PROJECT on PUBLIC PARTICIPATION
STRUCTURED DIALOGUE FOLLOW UP
THE FUTURE EVOLUTION OF CIVIL SOCIETY IN THE EUROPEAN UNION BY 2030
Consultation & Participation
The Role of Japanese CSOs in Promoting the SDGs
Boosting Non State Actor participation in CAADP Yaoundé 24th March 7Th CAADP PP CAADP NSA Coordination Task Team.
Meeting Outcomes “Building International Partnership To Enhance Science Based Ecosystem Approaches In Support Of Regional Ocean Governance” November.
Jørgen Friis, ETSI VP SES
A Guide to the Sharing Information on Progress (SIP)
Environment and Development Policy Section
UNCAC Coalition: An introduction
Presentation transcript:

MeTA Philippines Roberto M. Pagdanganan Title of presentation 04/02/2019 MeTA Philippines Roberto M. Pagdanganan Chairman, MeTA Council – Philippines Founding Chairman, Coalition for Health Advocacy and Transparency (CHAT) 04/02/2019 MeTA 1

Multi-stakeholder process Title of presentation 04/02/2019 Multi-stakeholder process [What were the major milestones in the multi-stakeholder process?] Dialogue, consultation & interaction among stakeholders as co-equals & partners Platform to stimulate exchange of information, transparency, accountability & governance Participation of both multinational & national industry associations (PHAP, PCPI) Engagement of professional organizations (PMA, PPhA) Organization of CSO coalition, the 1st alliance of health NGOs Close collaboration with int’l dev’t partners (WHO, WB, EC) Setting the stage to engage academe, media & other public health advocates 04/02/2019 MeTA 2

Major achievements and successes [What where the main achievements and successes of MeTA in your country? ] Three (3) annual national fora tackling health issues of current interest & developing concrete action plans Completion of the Pharmaceutical Sector Scan and Data Disclosure Survey, with room for validation & updating Support for the 1st National Awards for Good Governance in Medicines (GGM) Research projects: 1. Health financing systems for the poor, 2. Medicines promotion & advertising, 3.Assessment of public sector procurement, 4. Level II and III survey Participation in the MeTA Learning Exchange Program Launch of MeTA Discussion Series MeTA Philippines website 04/02/2019

Overall challenges [What have been the main challenges during the MeTA pilot phase? ] Some difficulty in sustaining the interest & improving the extent of participation of various stakeholders Strengthening adherence to the principles of transparency, accountability, governance, information sharing Willingness of stakeholders to disclose information Translating research results into meaningful action Lack of awareness about MeTA in the various publics Hastening implementation of projects identified in the approved Work Plan & maximizing budgetary resources Need to regularly assess relevance of projects in the light of current realities & developments 04/02/2019

Lessons Learned [What are the main lessons from MeTA in your country? ] Need for consensus-building in a multi-stakeholder environment to address concerns & resolve issues Importance of creating an atmosphere of trust & openness Need for greater willingness to share knowledge, information, resources Stronger commitment to goals & targets when all stakeholders are involved from planning to execution Access to relevant & accurate data is critical to arriving at sound & meaningful decisions Researches/surveys/studies must be translated into meaningful action & concrete programs 04/02/2019

Thank you Roberto M. Pagdanganan Title of presentation 04/02/2019 Thank you Roberto M. Pagdanganan Email: healthwatch1@yahoo.com Mobile number: +639272248271 Website: www.metaphilippines.org.ph 04/02/2019 MeTA